Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of BAHD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2263.26 | 1445 / 1445 | 100% | 23.01 | 183 / 183 |
thymus | 100% | 3541.10 | 653 / 653 | 100% | 41.72 | 605 / 605 |
lung | 100% | 2497.99 | 578 / 578 | 100% | 20.78 | 1152 / 1155 |
skin | 100% | 1876.91 | 1809 / 1809 | 100% | 23.04 | 470 / 472 |
adrenal gland | 100% | 3998.85 | 258 / 258 | 100% | 33.58 | 229 / 230 |
pancreas | 100% | 1499.20 | 328 / 328 | 99% | 19.25 | 177 / 178 |
prostate | 100% | 2145.19 | 245 / 245 | 99% | 18.49 | 499 / 502 |
breast | 100% | 1926.37 | 459 / 459 | 99% | 22.65 | 1111 / 1118 |
kidney | 100% | 2192.73 | 89 / 89 | 99% | 18.55 | 895 / 901 |
brain | 99% | 1423.24 | 2626 / 2642 | 100% | 21.57 | 704 / 705 |
intestine | 100% | 2298.09 | 966 / 966 | 99% | 18.80 | 523 / 527 |
bladder | 100% | 2397.38 | 21 / 21 | 99% | 18.58 | 500 / 504 |
uterus | 100% | 2583.44 | 170 / 170 | 99% | 20.35 | 455 / 459 |
ovary | 100% | 3963.25 | 180 / 180 | 99% | 19.71 | 426 / 430 |
stomach | 100% | 1960.84 | 359 / 359 | 99% | 19.87 | 283 / 286 |
liver | 100% | 1179.77 | 226 / 226 | 96% | 11.55 | 388 / 406 |
adipose | 100% | 1796.07 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1966.26 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.81 | 29 / 29 |
spleen | 100% | 2440.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.12 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.65 | 1 / 1 |
heart | 100% | 1573.73 | 860 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 15.58 | 79 / 80 |
muscle | 98% | 1401.37 | 786 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 70% | 823.98 | 646 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031507 | Biological process | heterochromatin formation |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005694 | Cellular component | chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005677 | Cellular component | chromatin silencing complex |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
Gene name | BAHD1 |
Protein name | Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1) |
Synonyms | KIAA0945 |
Description | FUNCTION: Heterochromatin protein that acts as a transcription repressor and has the ability to promote the formation of large heterochromatic domains. May act by recruiting heterochromatin proteins such as CBX5 (HP1 alpha), HDAC5 and MBD1. Represses IGF2 expression by binding to its CpG-rich P3 promoter and recruiting heterochromatin proteins. At specific stages of Listeria infection, in complex with TRIM28, corepresses interferon-stimulated genes, including IFNL1, IFNL2 and IFNL3. . |
Accessions | ENST00000561234.5 [Q8TBE0-2] Q8TBE0 ENST00000416165.6 [Q8TBE0-1] ENST00000560846.1 [Q8TBE0-3] |